156 related articles for article (PubMed ID: 31391375)
1. [Efficacy of Hedgehog inhibitors in acute myeloid leukemia and establishment of valid biomarkers].
Minami Y
Rinsho Ketsueki; 2019; 60(7):843-846. PubMed ID: 31391375
[TBL] [Abstract][Full Text] [Related]
2. Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment.
Terao T; Minami Y
Cells; 2019 Apr; 8(4):. PubMed ID: 30987263
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog Pathway Inhibitors: A New Therapeutic Class for the Treatment of Acute Myeloid Leukemia.
Jamieson C; Martinelli G; Papayannidis C; Cortes JE
Blood Cancer Discov; 2020 Sep; 1(2):134-145. PubMed ID: 34661144
[TBL] [Abstract][Full Text] [Related]
4. NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia.
Kakiuchi S; Minami Y; Miyata Y; Mizutani Y; Goto H; Kawamoto S; Yakushijin K; Kurata K; Matsuoka H; Minami H
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245563
[TBL] [Abstract][Full Text] [Related]
5. Nonhematopoietic cells represent a more rational target of in vivo hedgehog signaling affecting normal or acute myeloid leukemia progenitors.
Boyd AL; Salci KR; Shapovalova Z; McIntyre BA; Bhatia M
Exp Hematol; 2013 Oct; 41(10):858-869.e4. PubMed ID: 23747997
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia.
Shallis RM; Bewersdorf JP; Boddu PC; Zeidan AM
Expert Rev Anticancer Ther; 2019 Aug; 19(8):717-729. PubMed ID: 31422721
[No Abstract] [Full Text] [Related]
7. Targeting hedgehog in hematologic malignancy.
Irvine DA; Copland M
Blood; 2012 Mar; 119(10):2196-204. PubMed ID: 22223823
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog signaling inhibitors in solid and hematological cancers.
Cortes JE; Gutzmer R; Kieran MW; Solomon JA
Cancer Treat Rev; 2019 Jun; 76():41-50. PubMed ID: 31125907
[TBL] [Abstract][Full Text] [Related]
9. Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells.
Babashah S; Sadeghizadeh M; Hajifathali A; Tavirani MR; Zomorod MS; Ghadiani M; Soleimani M
Int J Cancer; 2013 Aug; 133(3):579-89. PubMed ID: 23341351
[TBL] [Abstract][Full Text] [Related]
10. Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms.
Ok CY; Singh RR; Vega F
Am J Pathol; 2012 Jan; 180(1):2-11. PubMed ID: 22056910
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
Brechbiel J; Miller-Moslin K; Adjei AA
Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure.
Lainez-González D; Serrano-López J; Alonso-Domínguez JM
Biology (Basel); 2021 Mar; 10(4):. PubMed ID: 33804919
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog pathway inhibitors: a patent review (2009--present).
Hadden MK
Expert Opin Ther Pat; 2013 Mar; 23(3):345-61. PubMed ID: 23294277
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling maintains chemoresistance in myeloid leukemic cells.
Queiroz KC; Ruela-de-Sousa RR; Fuhler GM; Aberson HL; Ferreira CV; Peppelenbosch MP; Spek CA
Oncogene; 2010 Dec; 29(48):6314-22. PubMed ID: 20802532
[TBL] [Abstract][Full Text] [Related]
15. JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML).
Maeda Y
Int J Hematol; 2024 Apr; 119(4):347-373. PubMed ID: 38483689
[No Abstract] [Full Text] [Related]
16. New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignancies.
Pimentel A; Velez M; Barahona LJ; Swords R; Lekakis L
Future Oncol; 2013 May; 9(5):681-97. PubMed ID: 23647297
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis.
Hofmann I; Stover EH; Cullen DE; Mao J; Morgan KJ; Lee BH; Kharas MG; Miller PG; Cornejo MG; Okabe R; Armstrong SA; Ghilardi N; Gould S; de Sauvage FJ; McMahon AP; Gilliland DG
Cell Stem Cell; 2009 Jun; 4(6):559-67. PubMed ID: 19497284
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with Hedgehog pathway inhibitors.
Low JA; de Sauvage FJ
J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
[TBL] [Abstract][Full Text] [Related]
19. [Drug resistance of leukemic stem cells mediated by hedgehog signaling pathway].
Xia PF; Peng Q; She MR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):250-3. PubMed ID: 23484730
[TBL] [Abstract][Full Text] [Related]
20. Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy.
Di Magno L; Coni S; Di Marcotullio L; Canettieri G
Biochim Biophys Acta; 2015 Aug; 1856(1):62-72. PubMed ID: 26080084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
